lab samples

Transplant Infectious Disease Program

The Transplant Infectious Disease Program, part of the Massachusetts General Hospital Transplant Center, is a part of the life-long care provided to organ, bone marrow and stem cell transplant recipients and others with increased risk for infections.

About this Program

Transplant patients take medicines after the transplantation to prevent the immune system from attacking their new organ. These medicines are essential for your health after transplantation. However, these medicines also reduce your body’s ability to defend itself against illness caused by infection from bacteria, viruses or fungi.

The Transplant Infectious Disease Program at Mass General provides:

  • Consultation for infectious disease management and prevention in transplant recipients and donors
  • Pre- and posttransplant vaccination and individually designed strategies for preventing infections
  • Travel advice in advance of or following travel by our patients

The integrated, multidisciplinary approach in the Transplant Infectious Disease Program involves all aspects of clinical care, basic, clinical and translational research, and education devoted to patients with an increased risk for infections.

Each member of the infectious disease team is committed to ensuring the best possible care for each patient with a compromised immune system as a result of organ, bone marrow or stem cell transplants.

The staff members of the Transplant Infectious Disease Program are all members of the Infectious Disease Division of Massachusetts General Hospital.

Conditions & Diseases

The care team at the Transplant Center encourages all patients and family members to learn more about conditions and diseases related to transplantation. The links below provide more information about conditions and diseases that might be treated within this program.

  • Cystic Fibrosis

    Cystic fibrosis (CF) is an inherited chronic disease that affects the lungs and digestive system. CF causes the body to produce thick, sticky mucus that leads to progressive lung infection and difficulty gaining weight.

  • Diabetes

    Type 1 diabetes may also be known by a variety of other names, including the following: insulin-dependent diabetes mellitus (IDDM), juvenile diabetes, brittle diabetes, or sugar diabetes.

  • End Stage Renal Disease (ESRD)

    Renal failure refers to temporary or permanent damage to the kidneys that results in loss of normal kidney function.

  • Heart Failure

    Heart failure, also called congestive heart failure, is a condition in which the heart cannot pump enough oxygenated blood to meet the needs of the body's other organs.

  • Hepatitis A

    Hepatitis A is a highly contagious and sometimes serious liver disease caused by the hepatitis A virus.

  • Hepatitis B

    Hepatitis B is a blood-borne microorganism transmitted by exposure to the hepatitis B virus through infectious body fluids.

  • Hepatitis C

    Hepatitis C (once called non-A, non-B hepatitis) is a liver disease caused by a recently identified blood-borne virus.

  • Pulmonary Emphysema

    Emphysema is a chronic lung condition in which alveoli, or air sacs, may be destroyed, narrowed, collapsed, stretched or over-inflated.

  • Pulmonary Sarcoidosis

    Sarcoidosis is a rare disease that results from inflammation.

  • Type 1 Diabetes

    Type 1 diabetes may also be known by a variety of other names, including the following: insulin-dependent diabetes mellitus (IDDM), juvenile diabetes, brittle diabetes, and sugar diabetes.

Patient Education

Mass General is dedicated to ensuring that people understand their health care choices and have the necessary information to make decisions affecting their health and well being. The related support and wellness information listed below can play a role in treatment options.




Contact Us

Transplant Infectious Disease Program

55 Fruit Street Boston, MA 02114
  • Near Public Transit
  • Handicapped Accessible
  • Phone: 617-726-3812

Back to Top